GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by D1 Capital Partners L.P.

D1 Capital Partners L.P. raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 22.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,486,584 shares of the company’s stock after buying an additional 629,270 shares during the quarter. GE HealthCare Technologies makes up approximately 4.5% of D1 Capital Partners L.P.’s portfolio, making the stock its 7th biggest position. D1 Capital Partners L.P. owned approximately 0.76% of GE HealthCare Technologies worth $272,581,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the company. Cathy Pareto & Associates Inc. acquired a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $670,000. Principal Financial Group Inc. increased its stake in GE HealthCare Technologies by 1.9% in the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock valued at $94,780,000 after buying an additional 19,010 shares during the period. Everence Capital Management Inc. raised its position in GE HealthCare Technologies by 118.2% during the 4th quarter. Everence Capital Management Inc. now owns 18,870 shares of the company’s stock worth $1,475,000 after buying an additional 10,220 shares during the last quarter. Apollon Wealth Management LLC lifted its stake in shares of GE HealthCare Technologies by 46.5% in the 4th quarter. Apollon Wealth Management LLC now owns 13,111 shares of the company’s stock worth $1,025,000 after acquiring an additional 4,160 shares during the period. Finally, Sanibel Captiva Trust Company Inc. boosted its holdings in shares of GE HealthCare Technologies by 139.9% in the fourth quarter. Sanibel Captiva Trust Company Inc. now owns 7,484 shares of the company’s stock valued at $585,000 after acquiring an additional 4,364 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

GEHC has been the subject of a number of recent analyst reports. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. BTIG Research set a $95.00 target price on GE HealthCare Technologies and gave the company a “buy” rating in a report on Monday, April 14th. Finally, The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and upped their price target for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. One analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $96.50.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $64.96 on Thursday. The stock has a fifty day moving average price of $77.57 and a 200 day moving average price of $82.50. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The firm has a market capitalization of $29.74 billion, a P/E ratio of 15.00, a PEG ratio of 3.19 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be paid a dividend of $0.035 per share. The ex-dividend date is Friday, April 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.22%. GE HealthCare Technologies’s dividend payout ratio is presently 3.23%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.